Tunisian Recommendations for a resumption of Reproductive Medicine activity in the Covid-19 pandemic

Authors

  • Marouen Braham
  • Mohamed Khrouf
  • Kais Chaabene
  • Sélima Fourati Ben Mustapha
  • Feten Hacheni
  • Lazhar Halouani
  • Khadija Kacem Berjeb
  • Walid Kerkeni
  • Chékib Mouelhi
  • Leila Attia Mahbouli
  • Mounir Ajina
  • Habib Midassi
  • Asma Ben Brahem Touil
  • Héla Ouertatani
  • Mohamed Ben Hamouda

Keywords:

Covid-19 , In vitro fertilization, antagonist protocol, vitrification, low responders, AMH

Abstract

The activity of the Reproductive Medicine poses a dilemma in this pandemic Covid-19. In fact, this is a theoretically non-emergency activity except for fertility preservation with oncological reasons. The majority of fertility societies in the world such as the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) recommended stopping the inclusion of new patients and continuing only the In Vitro Fertilization (IVF) cycles that have already been initiated by promoting Freeze-all as much as possible. Initilaly, the “Société Tunisienne de Gynécologie Obstétrique” (STGO) issued national recommendations that echo the international recommendations. These recommendations were followed by the majority of IVF center in Tunisia.
However, a number of new data are prompting us to update these recommendations.

Downloads

Download data is not yet available.

Downloads

Published

2020-06-01

Issue

Section

Recommandations